⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22097 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL28816648 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL21357306 | 0.95 | — | — | |
| SCHEMBL12212857 | 0.95 | — | — | |
| SCHEMBL7026104 | 0.95 | — | — | |
| SCHEMBL287369 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL19732657 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL15200590 | 0.91 | — | — | |
| Ammonia Solution, Strong SCHEMBL18669656 | 0.91 | — | — | |
| Methyl Alcohol SCHEMBL29281330 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638518-A1 | METHOD FOR PRODUCING AMIDO-METHYLATED VINYL-AROMATIC POLYMERIZATES | LANXESS Deutschland GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| CN-119591507-A | Gem-difluorocyclopentane compounds and methods of synthesizing the same | 南通大学 | 2025-03-11 | — | — | CN | claimed |
| CN-117895064-B | Phosphate polymer quasi-solid electrolyte, in-situ solid immobilization preparation method and application | 深圳大学 | 2024-11-19 | — | — | CN | claimed |
| WO-2024132827-A1 | METHOD FOR PRODUCING AMIDO-METHYLATED VINYL-AROMATIC POLYMERIZATES | LANXESS DEUTSCHLAND GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| EP-4385984-A1 | PYRIDINE-N-OXIDES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| CN-118019736-A | Molecular gel compound designed based on cereblon protein and application thereof | 标新生物医药科技(上海)有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117895064-A | Phosphate polymer quasi-solid electrolyte, in-situ solid immobilization preparation method and application | 深圳大学 | 2024-04-16 | — | — | CN | claimed |
| WO-2024051766-A1 | MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-03-14 | — | — | WO | claimed |
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | claimed |
| CN-116964048-A | Bicyclic tetrahydroazepine derivatives for the treatment of cancer | 豪夫迈·罗氏有限公司 | 2023-10-27 | — | — | CN | claimed |
| US-20160200741-A1 | Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection | HOFFMANN-LA ROCHE INC. (US) | 2016-07-14 | — | — | US | claimed |
| EP-3033341-A1 | NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | F.HOFFMANN-LA ROCHE AG (CH) | 2016-06-22 | — | — | EP | claimed |
| US-9206191-B2 | Indazoles for the treatment and prophylaxis of respiratory syncytial virus infection | HOFFMANN-LA ROCHE INC. (US) | 2015-12-08 | — | — | US | claimed |
| US-20150158879-A1 | Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection | HOFFMANN-LA ROCHE INC. (US) | 2015-06-11 | — | — | US | claimed |
| EP-2872502-A1 | NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2015-05-20 | — | — | EP | claimed |
| WO-2015022263-A1 | NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2015-02-19 | — | — | WO | claimed |
| WO-2014009302-A1 | NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2014-01-16 | — | — | WO | claimed |
| EP-1750776-A2 | OLIGONUCLEOTIDES COMPRISING A C5-MODIFIED PYRIMIDINE | Alnylam Pharmaceuticals Inc. (US) | 2007-02-14 | — | — | EP | claimed |
| WO-2006073458-A2 | OLIGONUCLEOTIDES COMPRISING A C5-MODIFIED PYRIMIDINE | ALNYLAM PHARMACEUTICALS, INC. (US) | 2006-07-13 | — | — | WO | claimed |
| US-20050288244-A1 | Oligonucleotides comprising a C5-modified pyrimidine | ALNYLAM PHARMACEUTICALS, INC. (US) | 2005-12-29 | — | — | US | claimed |